An overview of stress echocardiography in the study of patients with dilated or hypertrophic cardiomyopathy

Echocardiography

Volumn 21, Issue 5, 2004, Pages 467-475

  Wu, Wen Chih ^a,b   Bhavsar, Janak H ^a   Aziz, George F ^a   Sadaniantz, Ara ^a  

^a MIRIAM HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Amyl nitrite; Congestive heart failure; Dobutamine echocardiography; Isoproterenol; Stress echocardiography

Indexed keywords

CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EVALUATION; EXERCISE; EXERCISE TEST; HEALTH STATUS; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STRESS ECHOCARDIOGRAPHY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY, STRESS; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL CONTRACTION; STROKE VOLUME;

EID: 3042693768     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0742-2822.2004.03083.x     Document Type: Review

References (57)

1. Richardson P, Mckenna W, Bristow M, et al: Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996;93:841-842.
2. Reddy V, Korcarz C, Weinert L, et al: Apical hypertrophic cardiomyopathy. Circulation 1998;98:2354.
3. Maron BJ, Epstein SE: Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 1979;43:1242-1244.
4. Spirito P, Maron BJ, Bonow RO, et al: Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy. J Am Coll Cardiol 1986;8:537-544.
5. Maron BJ, Gottdiener JS, Arce J, et al: Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Doppler echocardiography. J Am Coll Cardiol 1985;6:1-15.
6. Okeie K, Shimizu M, Yoshio H, et al: Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2000;36:856-863.
7. Maron BJ, Wolfson JK, Epstein SE, et al: Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;8:545-557.
8. McKenna W, Deanfield J, Faruqui A, et al: Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981;47:532-538.
9. Roberts WC, Ferrans VJ: Pathologic anatomy of the cardiomyopathies. Idiopathic dilated and hypertrophic types, infiltrative types, and endomyocardial disease with and without eosinophilia. Human Pathol 1975;6:287-342.
10. Maron BJ, Spirito P, Green KJ, et al: Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1987;10:733-742.
11. Lewis JF, Maron BJ: Elderly patients with hypertrophic cardiomyopathy: A subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coll Cardiol 1989;13:36-45.
12. Cohn LH, Trehan H, Collins JJ: Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 1992;70:657-660.
13. Seggewiss H: Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy. Curr Cardiol Rep 2001;3:160-166.
14. Schwammenthal E, Vered Z, Rabinowitz B, et al: Stress echocardiography beyond coronary artery disease. Eur Heart J 1997;18(Suppl. D):D130-137.
15. Marwick TH, Nakatani S, Haluska B, et al: Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy. Am J Cardiol 1995;75:805-809.
16. Henein MY, O'Sullivan C, Sutton GC, et al: Stress-induced left ventricular outflow tract obstruction: A potential cause of dyspnea in the elderly. J Am Coll Cardiol 1997;30:1301-1307.
17. Kawano S, Iida K, Fujieda K, et al: Response to isoproterenol as a prognostic indicator of evolution from hypertrophic cardiomyopathy to a phase resembling dilated cardiomyopathy. J Am Coll Cardiol 1995;25:687-692.
18. Mishiro Y, Oki T, Yamada H, et al: Use of angiotensin II stress pulsed tissue Doppler imaging to evaluate regional left ventricular contractility in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2000;13:1065-1073.
19. Cardim N, Oliveira AG, Longo S, et al: Doppler tissue imaging: Regional myocardial function in hypertrophic cardiomyopathy and in the athlete's heart. J Am Soc Echocardiogr 2003;16:223-232.
20. Abernethy WB, Choo JK, Hutter AM: Echocardiographic characteristics of professional football players. J Am Coll Cardiol 2003;41:280-284.
21. Gadler F, Linde C, Juhlin-Dannfelt A, et al: Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest. Eur Heart J 1997;18:636-642.
22. Pellikka PA, Oh JK, Bailey KR, et al: Dynamic intraventricular obstruction during dobutamine stress echocardiography. A new observation. Circulation 1992;86:1429-1432.
23. Luria D, Klutstein W, Rosenmann D, et al: Prevalence and significance of left ventricular outflow gradient during dobutamine echocardiography. Eur Heart J 1999;20:386-392.
24. Schwammenthal E, Schwartzkopff B, Block M, et al: Doppler echocardiographic assessment of the pressure gradient during bicycle ergometry in hypertrophic cardiomyopathy. Am J Cardiol 1992;69:1623-1628.
25. Klues HG, Leuner C, Kuhn H: Left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: Increase in gradient after exercise. J Am Coll Cardiol 1992;19:527-533.
26. Weyman AE: Principles of flow. In Weyman AE (ed): Principles and Practices of Echocardiography, 2nd Ed. Canada, Lippincott, Williams, & Wilkins, 1994, pp. 184-200.
27. Hunt SA, Baker DW, Chin MH, et al: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001;38:2102-2113.
28. Diaz R, Obasohan A, Oakley C: Prediction of outcome in dilated cardiomyopathy. Br Heart J 1987;58:393-399.
29. DeMaria R, Gavazzi A, Recalcati F, et al: Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. Am J Cardiol 1993;72:580-585.
30. Dubois-Rande J, Merlet P, Roudot F, et al: B-Adrenergic contractile reserve as a predictor of clinical outcome in patients with idiopathic dilated cardiomyopathy. Am Heart J 1992;124:679-685.
31. Wong M, Johnson G, Shabetai R, et al: Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs Cooperative Studies V-HeFT I and II. Circulation 1993;87(Suppl. VI):65-70.
32. Pratali L, Picano E, Otasevic P, et al: Prognostic significance of the dobutamine echocardiography test in idiopathic dilated cardiomyopathy. Am J Cardiol 2001;88:1374-1378.
33. Ozaki N, Sugimoto T, Okada M: Assessment of left ventricular function using dobutamine stress echocardiography and myocardial scintigraphy in valvular heart disease. Kobe J Med Sci 1999;45:41-50.
34. Kitaoka H, Takata J, Yabe T, et al: Low dose dobutamine stress echocardiography predicts the improvement of left ventricular systolic function in dilated cardiomyopathy. Heart 1999;81:523-527.
35. Kono T, Nishina T, Morita H, et al: Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction. Am J Cardiol 1999;84:578-582.
36. Costanzo M, Augustine S, Bourge R, et al: Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995;92:3593-3612.
37. Paraskevaidis IA, Tsiapras DP, Adamopoulos S, et al: Assessment of the functional status of heart failure in non ischemic dilated cardiomyopathy: An echodobutamine study. Cardiovasc Res 1999;43:58-66.
38. Tischler MD, Niggel J, Borowski DT, et al: Relation between left ventricular shape and exercise capacity in patients with left ventricular dysfunction. J Am Coll Cardiol 1993;22:751-757.
39. Paraskevaidis IA, Adamopoulos S, Kremastinos DT: Dobutamine echocardiographic study in patients with non ischemic dilated cardiomyopathy and prognostically borderline values of peak exercise oxygen consumption. J Am Coll Cardiol 2001;37:1685-1691.
40. Paraskevaidis IA, Dodouras T, Amamopoulos S, et al: Effects of dobutamine on left ventriucar shape and geometry: An easy way to detect the functional status of chronic heart failure in patients with dilated cardiomyopathy. J Am Soc Echocardiogr 2003;16:132-139.
41. Hauser M, Gibson BS, Wilson N: Diagnosis of anthracycline-induced late cardiomyopathy by exercise-spiroergometry and stress-echocardiography. Eur J Pediatr 2001;160:607-610.
42. Klewer SE, Goldberg SJ, Donnerstein RL, et al: Dobutamine stress echocardiography: A sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. J Am Coll Cardiol 1992;19:394-401.
43. Campaniello M, Antonelli G, Di Venere N, et al: The echocardiographic assessment of the functional variations in the left ventricle induced by isometric stress in subjects with primary cardiomyopathy in the predilated phase. Cardiologia 1994;39:543-549.
44. Medina R, Panidis I, Morganroth J, et al: The value of echocardiographic regional wall motion abnormalities in detecting coronary artery disease in patients with or without a dilated left ventricle. Am Heart J 1985;109:799-802.
45. Kannel W, Abbott R: Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Eng J Med 1984;311:1144-1147.
46. Franchini M, Traversi E, Cannizzaro G, et al: Dobutamine stress echocardiography and thallium-201 SPECT for detecting ischaemic dilated cardiomyopathy in patients with heart failure. Eur J Echocardiogr 2000;1:109-115.
47. Franciosa J, Wilen M, Ziesche S, et al: Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831-836.
48. Vigna C, Russo A, Rito VD, et al: Regional wall motion analysis by dobutamine stress echocardiography to distinguish between ischemic and nonischemic dilated cardiomyopathy. Am Heart J 1996;131:537-543.
49. Bax JJ, Maddahi J, Poldermans D, et al: Preoperative evaluation of diffferent noninvasive strategies for predicting improvement of left ventricular function after coronary artery bipass grafting. Am J Cardiol 2003;92:1-4.
50. Djordjevic-Dikic A, Ostojic M, Beleslin B, et al: Low-dose adenosine stress echocardiography: Detection of myocardial viability. Cardiovasc Ultrasound 2003;1:1-7.
51. Borges AC, Richter WS, Witzel C, et al: Myocardial contrast echocardiography for predicting functional recovery after acute myocardial infarction. Int J Cardiovasc Imaging 2002;18:257-268.
52. Hillis GS, Mulvagh SL, Pellikka PA, et al: Comparison of intravenous myocardial contrast echocardiography and low-dose dobutamine echoardiography for predicting left ventricular functional recovery following acute myocardial infarction. Am J Cardiol 2003;92:504-508.
53. Voigt JU, Exner B, Schmiedehausen K, et al: Strain-rate imaging during dobutamine stress echocardiography provides objective evidence of inducible ischemia. Circulation 2003:2120-2126.
54. Urheim S, Edvardsen T, Torp H, et al: Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function. Circulation 2000;102:1158-1164.
55. Matsuoka M, Oki T, Mishoro Y, et al: Early systolic mitral annular motion velocities responses to dobutamine infusion predict myocardial viability in patients with previous myocardial infarction. Am Heart J 2002;143:552-558.
56. Hoffman R, Altiok E, Nowak B, et al: Strain rate measurement by Doppler echocardiography allows improved assessment of myocardial viability in patients with depressed left ventricular function. J Am Coll Cardiol 2002;39:443-449.
57. Cerqueira MD, Weissman NJ, Dilsizian V, et al: Standard myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for health care professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Am Soc Echocardiogr 2002;15:463-467.